Jump Financial’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.6K Sell
11,841
-49,359
-81% -$150K ﹤0.01% 2251
2026
Q2
$209K Buy
+61,200
New +$231K ﹤0.01% 1833
2025
Q1
– Sell
-215,725
Closed -$688K – 1618
2024
Q4
$688K Buy
+215,725
New +$1.76M 0.01% 929

Other funds holding CATX

Jump Financial's CATX Position: Q3 2026 in Review

Jump Financial reduced its Perspective Therapeutics (CATX) stake by 81% in Q3 2026, selling an estimated $150K and leaving 11,841 shares worth $32.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2251.

Jump Financial first reported a position in CATX in Q4 2024 and has held it in 3 quarters since. The position peaked at $688K in Q4 2024. 118 funds tracked by Wall St. Rank hold CATX as of Q3 2026.

  • Jump Financial held 11,841 shares of Perspective Therapeutics worth $32.6K as of Q3 2026.
  • Jump Financial sold 49,359 Perspective Therapeutics shares in Q3 2026, an estimated $150K.
  • Perspective Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #2251 holding.
  • Jump Financial first reported a position in Perspective Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Jump Financial's Perspective Therapeutics position peaked at $688K in Q4 2024.
  • 118 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.